Adolescent Medicine

Alcohol Abuse

Allergies and Infant Formula

Allergy, Immunology, and ENT

Animal Allergies

Autism

COVID-19

Cardiovascular Diseases

Cardiology

Pharmacology

Nutrition News

Telemedicine

Drug Pipeline News

Influenza

Emergency Medicine

Endocrinology

Gastroenterology

Infectious disease

Nutrition

Neurology

Obstetrics-Gynecology & Women's Health

Developmental/Behavioral Disorders

Practice Improvement

Gynecology

Respiratory

Dermatology

Mental Health

Oncology

Psychiatry

Skin Diseases

Rheumatoid Arthritis

Sexual Health

Clinical

Pain

Atopic Dermatitis

Acne

Diabetes

Diabetes Type 2

Antibiotic Resistance

Vaccination and Immunization

Bacterial Conjunctivitis

Vaccines

Anxiety

Depression

Concussion

Epilepsy

Headache

Food Allergies

Obesity

Childhood Obesity

Neonatal/Perinatology

ADHD

Antisocial Personality Disorder

Asthma

Cystic Fibrosis

Pediatric Asthma

Pneumonia

Sexually Transmitted Diseases

News 

All News

PNP Corner

AAP Guidelines

Media

Around the Practice

Cure Connections

Expert Interviews

Insights

Medical World News

Peer Exchange

Peers & Perspectives

Podcasts

Webinars

Puzzler

Publications

Contemporary Pediatrics Journal

Supplements And Featured Publications

CME/CE

Resources

Handouts

Job Board

Conferences

Conference Coverage

Conference Listing

Partnerships

Subscribe

Print Subscription

eNewsletter

Editorial

Editorial Advisory Board

Writer’s Guidelines

Reference Guidelines

Meet the Editors

Articles

The 20 children in the investigation had been diagnosed with ASD by PCPs who were trained using the ECHO (Extension for Community Healthcare Outcomes) Autism Screening Tool for Autism in Toddlers and Young Children (STAT). 

You may not need a specialist to diagnose ASD

Angelica Joshi, BA, is a research assistant in the Department of Pediatrics, Cohen Children’s Medical Center, New Hyde Park, NY.

*Co-first authorship was earned, as each equally contributed to the methodical and rigorous review of the literature, writing, and editing of this article.

Update on pediatric COVID-19 vaccination

Joshua Fitch is an editor for Contemporary Pediatrics. 

Tocilizumab-bavi (Tofidence; Biogen) demonstrated a biosimilarity to tocilizumab (Actemra; Genentech) based on multifaceted clinical and non-clinical data for polyarticular juvenile idiopathic arthritis (PJIA) and systemic juvenile idiopathic arthritis (sJIA) in children aged 2 years and up. This makes it the first tocilizumab biosimilar to be FDA-approved in the United States, according to Biogen. 

FDA approves tocilizumab-bavi as biosimilar for PJIA, SJIA in children 2 years and up 

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Contemporary Pediatrics week in review: CDC recommendation for RSV, FDA approved eye drops, and more

About Us

Advertise

Contact Us

Terms and Conditions

Privacy

Do Not Sell My Personal Information

Contemporary Pediatrics

Facebook

Twitter

LinkedIn

Instagram

Spotlight

2022 Best Tech

Changing Landscape in RSV Prevention

Food Insecurity and the Dangers of Infant Formula Dilution

Getting into the Roots of Childhood Atopic Dermatitis

Opt-Out Chlamydia Screening in Adolescent Care

The Role of the Healthcare Provider Community in Increasing Public Awareness of RSV in All Infants

Douglas W. Kress, MD

Articles